Rationale and design for fractional microablative CO₂ laser versus photothermal non-ablative erbium:YAG laser for the management of genitourinary syndrome of menopause: a non-inferiority, single-blind randomized controlled trial

References

• Portman DJ, Gass ML. On behalf of the Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and The North American Menopause Society. Climacteric. 2014;17:557–63
   PubMed Web of Science ®Google Scholar
• Wysocki S, Kingsberg S, Krychman M. Management of vaginal atrophy: Implications from the REVIVE survey. Clin Med Insights Reprod Health 2014;8:23–30
   PubMedGoogle Scholar
• Nappi RE, Particco M, Biglia N, et al. Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey. Maturitas 2016;91:74–80
   PubMed Web of Science ®Google Scholar
• Nappi RE, Palacios S, Panay N, et al. Vulvar and vaginal atrophy in four European countries: Evidence from the European REVIVE survey. Climacteric 2016;19:188–97
   PubMed Web of Science ®Google Scholar
• Juliato CR, Baccaro LF, Pedro AO, et al. Factors associated with urinary incontinence in middle-aged women: a population-based household survey. Int Urogynecol J 2017;28:423–9
   PubMed Web of Science ®Google Scholar
• Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509–22
   PubMed Web of Science ®Google Scholar
• Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society. Menopause 2013;20:888–902
   PubMed Web of Science ®Google Scholar
• Ettinger B, Hait H, Reape KZ, et al. Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach. Menopause 2008;15:885–9
   PubMed Web of Science ®Google Scholar
• Parish SJ, Nappi RE, Rychman ML. et al. Impact of vulvovaginal health on postmenopausal women: a review of surveys on symptoms of vulvovaginal atrophy. Int J Womens Health 2013;5:437–47
   PubMedGoogle Scholar
• Oge T, Hassa H, Aydin Y, et al. The relationship between urogenital symptoms and climacteric complaints. Climacteric 2013;16:646–52
   PubMed Web of Science ®Google Scholar
• Lester J, Pahouja G, Andersen B, et al. Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue. J Pers Med 2015;5:50–66
   PubMed Web of Science ®Google Scholar
• Crandall C, Petersen L, Ganz PA, et al. Association of breast cancer and its therapy with menopause-related symptoms. Menopause 2004;11:519–30
   PubMed Web of Science ®Google Scholar
• ACOG Committee Opinion No. 659. The use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Obstet Gynecol 2016;127:e93–6
   PubMed Web of Science ®Google Scholar
• Rahn DD, Carberry C, et al. Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. Obstet Gynecol 2014;124:1147–56
   PubMed Web of Science ®Google Scholar
• Athanasiou S, Pitsouni E, Antonopoulou S, et al. The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women. Climacteric 2016;19:512–18
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric 2015;18:757–63
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Levancini M. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause. Minerva Ginecol 2015;67:97–102
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Levancini M. Vaginal erbium laser: the second generation thermotherapy for the Genitourinary Syndrome of Menopause (GSM) in breast cancer survivors. A preliminary report of a pilot study. Int J Gynecol Obstet 2015;27:9–11
   Google Scholar
• Gaspar A, Brandi H, Gomez V, et al. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Laser Surg Med 2017;49:160–8
   PubMed Web of Science ®Google Scholar
• Perino A, Calligaro A, Forlani F, et al. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Maturitas 2015;80:296–301
   PubMed Web of Science ®Google Scholar
• Perino A, Cucinella G, Gugliotta G, et al. Is vaginal fractional CO2 laser treatment effective in improving overactive bladder symptoms in post-menopausal patients? Preliminary results. Eur Rev Med Pharmacol 2016;20:2491–7
   PubMed Web of Science ®Google Scholar
• Pieralli A, Fallani MG, Becorpi A, et al. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors. Arch Gynecol Oncol 2016;294:841–6
   Google Scholar
• Pitsouni E, Grigoriadis T, Tsiveleka A, Microablative fractional CO2-laser and the genitourinary syndrome of menopause: an observational study. Maturitas 2016;94:131–6
   PubMed Web of Science ®Google Scholar
• Salvatore S, Maggiore ULB, Origoni M, et al. Microablative fractional CO2 laser improves dyspareunia related to vulvovaginal atrophy: a pilot study. J Endom Pelv Pain Disord. 2014; doi: 10.5301/je.5000184
   PubMedGoogle Scholar
• Salvatore S, Nappi RE, Parma M, et al. Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy. Climacteric 2015;18:219–25
   PubMed Web of Science ®Google Scholar
• Salvatore S, Nappi RE, Zerbinati N, et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study. Climacteric 2014;17:363–9
   PubMed Web of Science ®Google Scholar
• Sokol E. Karram M. An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy. Menopause 2016;23:1102–7
   PubMed Web of Science ®Google Scholar
• Zerbinati N, Serati M, Origoni M, et al. Microscopic and ultrastructural modifications of postmenopausal atrophic dioxide treatment. Laser Med Sci 2015;30:429–36
   PubMed Web of Science ®Google Scholar
• Pitsouni E, Grigoriadis T, Falagas ME, et al. Laser therapy for genitourianry syndrome of menopause. A systematic review and meta-analysis. Maturitas 2017;103:78–88
   PubMed Web of Science ®Google Scholar
• Rosen R, Brown C, Heiman J, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191–208
   PubMed Web of Science ®Google Scholar
• Huang AJ, Gregorich SE, Kuppermann M, et al. The Day-to-Day impact of vaginal aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and Well-being in postmenopausal women. Menopause 2015;22:144–54
   PubMed Web of Science ®Google Scholar
• Zhong B. How to calculate sample size in randomized controlled trial? J Thorac Dis 2009;1:51–4
   PubMedGoogle Scholar
• Weber MA, Limpens J, Roovers JPWR. Assessment of vaginal atrophy: a review. Int Urogynecol J 2015;26:15–28
   PubMed Web of Science ®Google Scholar